Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20180531002Not yet recruiting
Randomised trial of leflunomide (2 arms), sponsored by All Research. Primary endpoints: Cmax and AUC0-120. Planned start Jul 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20180531002.